Aug 13, 2026 08:30AM
Jun 12, 2026 08:10AM
May 13, 2026 08:30AM
Feb 26, 2026 09:00AM
Nov 13, 2025 04:33PM
Nov 13, 2025 08:30AM
Aug 13, 2025 05:24AM Fate Therapeutics (FATE) PT Lowered to $2.50 at Wells Fargo
Aug 12, 2025 05:31PM
Aug 12, 2025 04:01PM
May 14, 2025 04:30AM
May 13, 2025 06:12PM
May 13, 2025 04:01PM
Mar 5, 2025 04:53PM
Mar 5, 2025 04:01PM Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
Nov 12, 2024 09:22PM
Nov 12, 2024 04:01PM
Aug 13, 2024 05:07PM
Aug 13, 2024 05:07PM
Aug 13, 2024 04:05PM
May 9, 2024 04:05PM
May 9, 2024 04:01PM Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
May 6, 2024 08:00AM
Feb 26, 2024 04:08PM
Feb 26, 2024 04:01PM
Feb 15, 2024 08:00AM
Nov 8, 2023 04:04PM
Nov 8, 2023 04:01PM
Oct 25, 2023 08:00AM Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2023 Financial Results
Aug 8, 2023 04:17PM
Aug 8, 2023 04:01PM
Jul 28, 2023 08:00AM
May 3, 2023 04:05PM
May 3, 2023 04:01PM
Apr 24, 2023 08:00AM
Apr 24, 2023 08:00AM Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2023 Financial Results
Mar 6, 2023 09:00PM
Feb 28, 2023 04:06PM
Feb 28, 2023 04:01PM
Feb 28, 2023 04:01PM
Feb 19, 2023 09:00PM
Feb 13, 2023 08:00AM
Feb 8, 2023 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bioventus, ESS, IBM, and FATE and Encourages Investors to Contact the Firm
Feb 3, 2023 09:00PM
Jan 18, 2023 09:00PM
Nov 3, 2022 04:06PM
Nov 3, 2022 04:01PM
Nov 3, 2022 04:01PM
Oct 24, 2022 04:01PM
Oct 24, 2022 04:01PM Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2022 Financial Results
Aug 3, 2022 04:01PM

1,222,859 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All